57 related articles for article (PubMed ID: 34989325)
1. A prospective comparison of common toxicity criteria adverse events Version 3 and 4 in assessing oral mucositis for oral and oropharyngeal carcinoma.
Hickman M; Meade SJ; Fong C; Sanghera P; Good J; Hartley A
Tech Innov Patient Support Radiat Oncol; 2017 Mar; 1():18-21. PubMed ID: 32095539
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Lvpao Powder on Radiation Therapy-Induced Mucositis: A Retrospective Study of 114 Patients With Head and Neck Carcinoma.
Chen L; Lu F; Qian H; Wang H; Zhang F
Adv Radiat Oncol; 2024 Apr; 9(4):101434. PubMed ID: 38778827
[TBL] [Abstract][Full Text] [Related]
3. Prevention and management of antineoplastic therapy induced oral mucositis.
Bey A; Ahmed SS; Hussain B; Devi S; Hashmi SH
Natl J Maxillofac Surg; 2010 Jul; 1(2):127-34. PubMed ID: 22442583
[TBL] [Abstract][Full Text] [Related]
4. Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial.
Tang LL; Guo R; Zhang N; Deng B; Chen L; Cheng ZB; Huang J; Hu WH; Huang SH; Luo WJ; Liang JH; Zheng YM; Zhang F; Mao YP; Li WF; Zhou GQ; Liu X; Chen YP; Xu C; Lin L; Liu Q; Du XJ; Zhang Y; Sun Y; Ma J
JAMA; 2022 Aug; 328(8):728-736. PubMed ID: 35997729
[TBL] [Abstract][Full Text] [Related]
5. Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.
Zhang Y; Chen L; Hu GQ; Zhang N; Zhu XD; Yang KY; Jin F; Shi M; Chen YP; Hu WH; Cheng ZB; Wang SY; Tian Y; Wang XC; Sun Y; Li JG; Li WF; Li YH; Mao YP; Zhou GQ; Sun R; Liu X; Guo R; Long GX; Liang SQ; Li L; Huang J; Long JH; Zang J; Liu QD; Zou L; Su QF; Zheng BM; Xiao Y; Guo Y; Han F; Mo HY; Lv JW; Du XJ; Xu C; Liu N; Li YQ; Xie FY; Sun Y; Ma J; Tang LL
J Clin Oncol; 2022 Aug; 40(22):2420-2425. PubMed ID: 35709465
[No Abstract] [Full Text] [Related]
6. The application of the PDCA cycle in the nutritional management of patients with nasopharyngeal carcinoma.
Zeng X; Huang X; Wang P; Liao J; Wu L; Liu J; Wu H; Wei R
Support Care Cancer; 2023 Apr; 31(5):251. PubMed ID: 37036536
[TBL] [Abstract][Full Text] [Related]
7. Prevention and the treatment of oral mucositis: the efficacy of sodium bicarbonate vs other agents: a systematic review.
Di Fede O; Canepa F; Maniscalco L; Tozzo P; Matranga D; Giuliana G
BMC Oral Health; 2023 Jan; 23(1):4. PubMed ID: 36597048
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 protects against radiation-induced oral mucositis via antioxidation and keratin layer thickening.
Wakamori S; Taguchi K; Nakayama Y; Ohkoshi A; Sporn MB; Ogawa T; Katori Y; Yamamoto M
Free Radic Biol Med; 2022 Aug; 188():206-220. PubMed ID: 35753588
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis.
Lee CT; Galloway TJ
Curr Treat Options Oncol; 2022 Mar; 23(3):311-324. PubMed ID: 35244887
[TBL] [Abstract][Full Text] [Related]
10. Application value of self-management manual combined with case management superiority model in postoperative management of nasopharyngeal carcinoma after radiotherapy.
Hu L; Xu Y; Xu Y
Am J Transl Res; 2023; 15(7):4951-4961. PubMed ID: 37560242
[TBL] [Abstract][Full Text] [Related]
11. Update on the treatment of chemotherapy and radiotherapy-induced buccal mucositis: a systematic review.
Wen S; Brito L; Santander J; Conteras G
Acta Odontol Latinoam; 2023 Apr; 36(1):3-14. PubMed ID: 37314054
[TBL] [Abstract][Full Text] [Related]
12. Management of Oral Hygiene in Head-Neck Cancer Patients Undergoing Oncological Surgery and Radiotherapy: A Systematic Review.
Lanzetti J; Finotti F; Savarino M; Gassino G; Dell'Acqua A; Erovigni FM
Dent J (Basel); 2023 Mar; 11(3):. PubMed ID: 36975580
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy of the anti-ulcer oral mucosal protective agent RADoralex® in the prevention and treatment of radiation-induced oral mucosal reactions induced during treatment of nasopharyngeal carcinoma.
Yin J; Xie J; Lin J; Weng C; Lu S; Xu P; Zhang S; Luo C; Huang Y; Li L; Lang J; Feng M
Cancer Biol Ther; 2022 Dec; 23(1):27-33. PubMed ID: 34989325
[TBL] [Abstract][Full Text] [Related]
14. The effects of recombinant human granulocyte colony-stimulating factor mouthwash on radiotherapy-induced oral mucositis in locally advanced nasopharyngeal carcinoma patients.
Liang G; Du W; Ke Q; Huang B; Yang J
Adv Clin Exp Med; 2017; 26(3):409-413. PubMed ID: 28791814
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open-label, randomized controlled trial.
Liang L; Liu Z; Zhu H; Wang H; Wei Y; Ning X; Shi Z; Jiang L; Lin Z; Yan H; Wang R; Hu K
Cancer; 2022 Apr; 128(7):1467-1474. PubMed ID: 34910297
[TBL] [Abstract][Full Text] [Related]
16. [Effect of Kou Yan Qing Ke Li on the prevention and treatment of radiation-induced oral mucositis in patients with nasopharyngeal carcinoma].
Yun G; Li Z; Zehui F; Xudong H
Hua Xi Kou Qiang Yi Xue Za Zhi; 2016 Feb; 34(1):37-40. PubMed ID: 27266196
[TBL] [Abstract][Full Text] [Related]
17. Incidence and Risk Factors for Radiotherapy-Induced Oral Mucositis Among Patients With Nasopharyngeal Carcinoma: A Meta-Analysis.
Li J; Zhu C; Zhang Y; Guan C; Wang Q; Ding Y; Hu X
Asian Nurs Res (Korean Soc Nurs Sci); 2023 May; 17(2):70-82. PubMed ID: 37094771
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory mouthwashes for the prevention of oral mucositis in cancer therapy: an integrative review and meta-analysis.
Thornton CP; Li M; Budhathoki C; Yeh CH; Ruble K
Support Care Cancer; 2022 Sep; 30(9):7205-7218. PubMed ID: 35486227
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
